Anticoagulation management : a guidebook for pharmacists /: a guidebook for pharmacists. (2015)

• Record Type: Book
• Further Information: Note: Anne Rose, editor.
• Editors: Rose, Anne
• Contents: Anticoagulation Management; Preface; Abbreviations; Contents; Contributors; Part 1: Medication Management; Chapter 1: Inpatient Warfarin Management; 1.1 Introduction; 1.2 Case Examples; 1.2.1 Case 1; 1.2.2 Case 2; 1.2.3 Case 3; 1.3 Role of the Pharmacist in Inpatient Vitamin K Antagonist Management; 1.4 Warfarin Management Guidelines and Protocols; 1.4.1 Warfarin Initiation; 1.4.2 Warfarin Maintenance; 1.5 Monitoring and Interpreting Laboratory Values; 1.5.1 International Normalized Ratio (INR); 1.5.2 Complete Blood Count (CBC); 1.5.3 Pregnancy Testing; 1.5.4 Genetic Testing. 1.6 Assessment of Drug Interactions1.7 Patient Education; 1.8 Documentation; 1.9 Conclusions; References; Chapter 2: Ambulatory Warfarin Management; 2.1 Introduction; 2.2 Case Examples; 2.2.1 Case 1; 2.2.2 Case 2; 2.2.3 Case 3; 2.3 Role of the Pharmacist in Ambulatory Warfarin Management; 2.4 Warfarin Management Guidelines and Protocols; 2.4.1 Indication for Warfarin Therapy; 2.4.2 Patient Assessment; 2.4.3 Initial Warfarin Dosing; 2.4.4 Maintenance Warfarin Dosing; 2.5 Monitoring Laboratory Values and Patient Assessment; 2.5.1 Monitoring Laboratory Values; 2.5.2 Patient Assessment. 2.6 Assessment of Drug Interactions2.7 Patient Education and Compliance; 2.7.1 Patient Education; 2.7.2 Patient Compliance; 2.8 Documentation; 2.9 Conclusion; References; Chapter 3: Unfractionated Heparin and Low Molecular Weight Heparin; 3.1 Introduction; 3.2 Case Examples; 3.2.1 Case 1; 3.2.2 Case 2; 3.2.3 Case 3; 3.3 The Role of the Pharmacist; 3.3.1 UFH Management; 3.3.2 LMWH Management; 3.4 Management Guidelines and Protocols; 3.4.1 UFH Management Guidelines and Protocols; 3.4.2 LMWH Management; 3.5 Monitoring and Interpreting Laboratory Values; 3.5.1 Maintenance Monitoring of UFH. 3.5.2 Maintenance Monitoring of LMWH3.6 Documentation; 3.7 Patient Education; 3.8 Future Roles; 3.9 Conclusion; References; Chapter 4: Direct Oral Anticoagulants; 4.1 Introduction; 4.2 Case Examples; 4.2.1 Case 1; 4.2.2 Case 2; 4.3 Pharmacist Role in DOAC Management; 4.4 DOAC Drug Selection and Management; 4.4.1 Anticoagulant Selection [5-17]; Prosthetic Heart Valves; Geriatric Patients; Renal Impairment; Dialysis; Hepatic Impairment; Pregnancy/Lactation; Pediatrics; Contraindications; 4.4.2 DOAC Selection; 4.4.3 DOAC Dosing; 4.5 Monitoring and Interpreting Laboratory Values. 4.5.1 Labs to Determine Coagulation Status [20, 21]4.5.2 Labs to Monitor for Appropriate DOAC Dosing [8-17, 19]; 4.6 Drug Interactions [22]; 4.6.1 Pharmacokinetic Drug Interactions; P-gp Inhibitors and Inducers; CYP 3A4 Inhibitors and Inducers; 4.6.2 Pharmacodynamic Drug Interactions; Medications that Inhibit Platelet (PLT) Aggregation; 4.7 Transitioning Between Anticoagulants [23-25, 27]; 4.7.1 Periprocedural Planning; 4.7.2 Reversal Strategies [28]; 4.8 Patient Education [19]; 4.9 Future Roles; 4.9.1 Anticoagulation Clinics; 4.9.2 Reimbursement; 4.10 Conclusion; References.
• Publisher Details: Cham : Adis
• Publication Date: 2015
• Extent: 1 online resource
• Subjects: 615.718; Medicine; Anticoagulants (Medicine); Anticoagulants (Medicine); Anticoagulants -- therapeutic use; Medical -- Pharmacology; Pharmacology; Medical -- General; Medical research; Electronic books
• Languages: English
• ISBNs: 9783319226026; 3319226029
• Related ISBNs: 9783319226019; 3319226010; 9783319226019
• Notes: Note: Includes bibliographical references.; Note: Online resource; title from PDF title page (EBSCO, viewed October 7, 2015).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.